首页> Frontiers in immunology> Islet organoids: a new hope for islet transplantation in diabetes.

Islet organoids: a new hope for islet transplantation in diabetes.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xuemei,Yu

第一单位： Department of Clinical Nutrition, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

作者： Xuemei,Yu ^[1] ; Chengkong,Liu ^[2] ; Zheng,Kuang ^[2] ; Siyuan,Song ^[3] ; Limin,Tian ^[4] ; Yi,Wang ^[5]

作者单位： Department of Clinical Nutrition, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. ^[1] School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. ^[2] Department of Neuroscience, Baylor College of Medicine, Houston, TX, United States. ^[3] Center for Geriatrics and Endocrinology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. ^[4] Center for Geriatrics and Endocrinology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.;Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. ^[5]

关键词 Procr+ progenitors chemically induced pluripotent stem cells (CiPSCs)diabetes treatment endoderm stem cells (EnSCs)islet organoids islet transplantation personalized therapy β-cell regeneration